Healthcare/Life Sciences

J&J, Merck and Bristol Myers CEOs, below fireplace on Capitol Hill, search to show up warmth on drug-market middlemen 

This fund supervisor stopped worrying about economics. Now he’s outperforming the inventory market.

Amgen’s quarterly outcomes prime expectations regardless of Enbrel gross sales decline

Enphase’s ‘good enough’ quarter pushes inventory 12% increased

AI can save us and the planet — however we would not be sensible sufficient, Roubini says

Novartis to bolster its oncology portfolio with acquisition of MorphoSys

Small companies are paying 100%+ of earnings to Uncle Sam after tax-law change

Novo Nordisk’s controlling shareholder to purchase Catalent for $16.5 billion

Some board members felt pressured to take medication with Elon Musk, WSJ experiences

Amer Sports inventory ends its first day of buying and selling with a 3% achieve over its discounted IPO worth